Staphylococcus cohnii septicaemia in a patient with colon cancer.
A coagulase-negative staphylococcal strain was isolated from peripheral blood and central venous catheter blood of a febrile patient with cancer. This isolate, initially classified by a commercial test as Staphylococcus kloosii, was definitively assigned to Staphylococcus cohnii by physiological and molecular tests. The strain lacked virulence factors, such as biofilm production and haemagglutination, and was sensitive to the antibiotics tested. The data suggest that rare micro-organisms with low pathogenic potential can cause severe illness in cancer patients; reference identification is required, however, to describe correctly the epidemiological characteristics and virulence factors of these clinical isolates.
Basaglia
Giancarlo
G
Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
Moras
Laura
L
Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
Bearz
Alessandra
A
Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
Scalone
Simona
S
Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
Paoli
Paolo De
P
Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000150:complications* / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D013210:Staphylococcus / Q000145:classification* / Q000302:isolation & purification* / Q000472:pathogenicity; D037521:Virulence Factors / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D037521:Virulence Factors; D002442:Ceftazidime